Markets:

Overview

News

Currencies

International

Treasuries

CTI BioPharma Corp. - Common Stock (NQ:CTIC)

N/A UNCHANGED

Last Price Updated: 4:00 PM EDT, Jun 23, 2023 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

Headline News about CTI BioPharma Corp. - Common Stock

< Previous 1 2 3 4 Next >

80 Biggest Movers From Yesterday ↗

March 02, 2022

Gainers Avenue Therapeutics, Inc. (NASDAQ: ATXI) jumped 78.5% to close at $0.6066 on Tuesday after jumping 36% on Monday. CTI BioPharma Corp. (NASDAQ: CTIC) surged 63...

Via Benzinga

12 Health Care Stocks Moving In Tuesday's Intraday Session ↗

March 01, 2022

Gainers Avenue Therapeutics (NASDAQ:ATXI) shares rose 172.1% to $0.92 during Tuesday's regular session. As of 12:30 EST, this security is trading at a volume of 157.8...

Via Benzinga

12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗

March 01, 2022

Gainers Avenue Therapeutics (NASDAQ:ATXI) shares rose 102.3% to $0.69 during Tuesday's pre-market session. The market value of their outstanding shares is at $14.3...

Via Benzinga

The Daily Biotech Pulse: Legend Biotech, CTI Biopharma Receive FDA Approvals, AbbVie Announces Delay In Skyrizi Review, Editas Gains On CRISPR Patent Resolution ↗

March 01, 2022

Here's a roundup of top developments in the biotech space over the last 24 hours: Stocks In Focus Editas Gains On Resolution Of CRISPR Gene Editing Patent Case Editas Medicine...

Via Benzinga

CTI BioPharma's Bone Marrow Cancer Drug Scores FDA Approval ↗

March 01, 2022

The FDA approved CTI BioPharma Corp's (NASDAQ: CTIC) Vonjo (pacritinib) for treating adult patients with myelofibrosis, a type of bone marrow cancer with low...

Via Benzinga

12 Health Care Stocks Moving In Monday's Pre-Market Session ↗

February 28, 2022

Gainers Soleno Therapeutics (NASDAQ:SLNO) shares rose 15.7% to $0.37 during Monday's pre-market session. The market value of their outstanding shares is at $29.5...

Via Benzinga

67 Biggest Movers From Yesterday ↗

March 01, 2022

Gainers Mullen Automotive, Inc. (NASDAQ: MULN) climbed 145.6% to close at $1.69 on Monday after the company reported progress on solid-state polymer battery pack...

Via Benzinga

The Week Ahead In Biotech (Feb. 27-March 5): Earnings, Multiple Regulatory Decisions Take The Spotlight ↗

February 27, 2022

Biopharma stocks lock-stepped with the broader market in the week ending Feb. 25 before finishing higher. The trajectory was the same, with the sector declining in the first two sessions of the...

Via Talk Markets

The Week Ahead In Biotech (Feb. 27-March 5): Earnings, Multiple Regulatory Decisions Take The Spotlight ↗

February 27, 2022

Biopharma stocks lock-stepped with the broader market in the week ending Feb. 25 before finishing higher. The trajectory was the same, with the sector declining in the first...

Via Benzinga

Attention Biotech Investors: Mark Your Calendar For These Key February PDUFA Dates ↗

February 01, 2022

After a fairly robust 2021, the new year started on a mixed note as far as regulatory decisions are concerned.

Via Benzinga

12 Health Care Stocks Moving In Friday's Intraday Session ↗

December 03, 2021

Gainers Celyad Oncology (NASDAQ:CYAD) stock moved upwards by 32.58% to $4.72 during Friday's regular session. Trading volume for this security as of 12:30 EST is 45.2...

Via Benzinga

The Week Ahead In Biotech (Dec. 6-Dec. 11): Daré FDA Decision, Adcom Tryst For Reata, Multiple Conference Presentations And More ↗

December 06, 2021

The omicron variant concerns were front and center in the markets in the week ended Dec. 3, and biotech stocks did not escape the brunt of selling in the wake of the negative...

Via Benzinga

4 Penny Stocks Insiders Are Buying ↗

December 03, 2021

When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders intereste...

Via Benzinga

61 Biggest Movers From Yesterday ↗

December 02, 2021

Gainers Arbutus Biopharma Corporation (NASDAQ: ABUS) shares jumped 44.1% to close $4.61 on above-average volume on Wednesday. The Patent Trial and Appeals Board has turned down...

Via Benzinga

Topics Intellectual Property

Mid-Afternoon Market Update: Dow Rises Over 100 Points; CTI BioPharma Shares Plummet ↗

December 01, 2021

Toward the end of trading Wednesday, the Dow traded up 0.39% to 34,617.2 while the NASDAQ climbed 0.17% to 15,564.73. The S&P also rose, gaining 0.68% to 4,597.96. The U.S....

Via Benzinga

Topics Stocks

Why CTI BioPharma Stock Is Plunging Today ↗

December 01, 2021

The FDA extended its review period for myelofibrosis candidate pacritinib.

Via The Motley Fool

12 Health Care Stocks Moving In Wednesday's Intraday Session ↗

December 01, 2021

Gainers Ardelyx (NASDAQ:ARDX) shares rose 25.87% to $1.44 during Wednesday's regular session. As of 12:30 EST, this security is trading at a volume of 215.1 million...

Via Benzinga

Mid-Morning Market Update: Markets Open Higher; G-III Apparel Earnings Beat Views ↗

December 01, 2021

Following the market opening Wednesday, the Dow traded up 0.99% to 34,824.47 while the NASDAQ climbed 1.40% to 15,755.57. The S&P also rose, gaining 1.39% to 4,630.57. The U.S...

Via Benzinga

Topics Earnings Stocks

The Daily Biotech Pulse: Adcom Backs Merck's Oral COVID-19 Treatment; Regulatory Setbacks For CTI Biopharma, BioXcel; Favorable Ruling For Viatris In Tecfidera Patent Case ↗

December 01, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours: Stocks In Focus Merck Gets Adcom Backing For Oral COVID-19 Antiviral Medication Molnupiravir...

Via Benzinga

Topics Intellectual Property

50 Stocks Moving In Wednesday's Mid-Day Session ↗

December 01, 2021

Gainers Arbutus Biopharma Corporation (NASDAQ: ABUS) climbed 91.7% to $6.14 on above-average volume on Wednesday. The Patent Trial and Appeals Board has turned down Moderna's...

Via Benzinga

Topics Intellectual Property

12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗

December 01, 2021

Gainers Ardelyx (NASDAQ:ARDX) stock increased by 19.29% to $1.36 during Wednesday's pre-market session. The market value of their outstanding shares is at $153.3...

Via Benzinga

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday ↗

December 01, 2021

Good morning, traders! We're starting off the day right with a look at the biggest pre-market stock movers for Wednesday!

Via InvestorPlace

23 Stocks Moving in Wednesday's Pre-Market Session ↗

December 01, 2021

Gainers Skylight Health Group Inc. (NASDAQ: SLHG) rose 55.3% to $2.05 in pre-market trading after dipping around 10% on Tuesday. Skylight Health Group, last month, posted a...

Via Benzinga

FDA Extends Review Period For CTI BioPharma's Bone Marrow Cancer Candidate ↗

December 01, 2021

The FDA has extended the review period for CTI BioPharma Corp's (NASDAQ: CTIC) pacritinib marketing application for myelofibrosis. The application for...

Via Benzinga

52 Biggest Movers From Yesterday ↗

December 01, 2021

Gainers Cumberland Pharmaceuticals Inc. (NASDAQ: CPIX) shares climbed 128.6% to close at $5.03 on Tuesday. The FDA approved expanded labeling for Cumberland...

Via Benzinga

The Daily Biotech Pulse: Cumberland Jumps On FDA Nod, Regeneron Says Antibody Treatment May Be Less Effective Against Omicron, ImmunoGen Readout ↗

November 30, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours: Stocks In Focus Cumberland Gets FDA Approval For IV-Delivered Ibuprofen For Use In Pre-...

Via Benzinga

20 Stocks Moving In Tuesday's Pre-Market Session ↗

November 30, 2021

Gainers Cumberland Pharmaceuticals Inc. (NASDAQ: CPIX) rose 117.3% to $4.78 in pre-market trading after the company announced the FDA approved expanded labeling for Caldolor to...

Via Benzinga

The Week Ahead In Biotech (Nov. 28-Dec. 4): FDA Decisions For VBI Vaccines, & More ↗

November 28, 2021

Biotech stocks advanced in the week ending Nov. 26, as a late-week surge on the back of news about a new COVID-19 variant helped mitigate the losses notched earlier in the holiday-shortened week.

Via Talk Markets

The Week Ahead In Biotech (Nov. 28-Dec. 4): FDA Decisions For VBI Vaccines, BeyondSpring, CTI Biopharma And Merck Take The Spotlight In A Light Calendar Week ↗

November 28, 2021

Biotech stocks advanced in the week ending Nov. 26, as a late-week surge on the back of news about a new COVID-19 variant, named Omicron, helped mitigate the losses...

Via Benzinga

Attention Biotech Investors: Mark Your Calendar For November PDUFA Dates ↗

November 02, 2021

The loaded Prescription Drug User Fee Act (PDUFA) calendar for October produced mixed outcomes. PDUFA dates are key binary events for biotech stocks that can move the needle in a...

Via Benzinga

< Previous 1 2 3 4 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

CTI BioPharma Corp. - Common Stock (NQ:CTIC)

Headline News about CTI BioPharma Corp. - Common Stock

Starting at $3.75/week.

Subscribe Today